+44 (0)207 848 0138
I graduated in medicine from Glasgow University in 1980 and trained in neurology before entering psychiatry at the Maudsley Hospital, London. I also have a Masters degree in Cognitive Neuropsychology. I have been an honorary consultant at the Maudsley since 1990 and was awarded a personal chair from the Institute of Psychiatry, King’s College London in 1996. I was appointed Vice Dean for Academic Psychiatry in 2013.
I am a Fellow of the Royal College of Physicians, the Royal College of Psychiatrists and the Academy of Medical Sciences. I am also a member of the Experimental Psychology Society and a founder member of both the British Neuropsychological Society and British Neuropsychiatry Association - I was Chairman to the latter from 2004-7.
I am editor of the journal “Cognitive Neuropsychiatry”, and have co-edited several books including The Neuropsychology of Schizophrenia (1994) with J. Cutting, Disorders of Brain and Mind (1998) with M. Ron, The Self in Neuroscience and Psychiatry (2003) with T Kircher, and Insight and Psychosis (2nd Ed) (2004) with X. Amador and Lishman’s Organic Psychiatry (2009). I am author of just over 500 publications in peer reviewed medical and scientific journals.
2013 Vice Dean for Academic Psychiatry, Institute of Psychiatry, Kings College London, UK
1996 Professor of Cognitive Neuropsychiatry, Institute of Psychiatry, Kings College London, UK
1990 Honorary consultant, the Maudsley Hospital, London, UK
MD Glasgow University UK
MSc Cognitive Neuropsychology, Birkbeck College, University of London
MBChB Glasgow University, UK
I have a wide and diverse range of research interests including schizophrenia, neuropsychiatry, medically unexplained syndromes and neuroimaging – both structural and functional. I am especially interested in the concept of insight in schizophrenia and how this relates to treatment compliance.
I am overall head of the Clinical Disorders Cluster for the BRC as well as leading the Neuropsychiatry Theme within the Cluster. This involves setting the strategy and overseeing the activity within each of the component disorder clusters. To date, this has included work on the BRC/Genetics and Psychosis Study, developing treatments for impulse control disorders in Parkinson Disease and the therapeutic use of transcranial magnetic stimulation.